Ibuprofen API Market Value to Surge 1.3X Through 2029
The pharmaceutical industry is embracing a transformative development curve in an effort to fulfil its core objective - developing effective and new-age drugs brought to patients with timeliness and efficiency. Innovations aid ease the burden off patients and healthcare professionals while streamlining the manufacturing of drugs such as specialty active pharmaceutical ingredients (API), and decreasing cost. Pharmaceutical companies are realizing substantial returns with such innovative approaches from a patient-centered perspective. Propelled by this transition, the global adoption of ibuprofen API will boost over 1.3x over the forecast period, 2019-2029.
Key Factors Shaping Ibuprofen APIs Market
Ibuprofen APIs Continue to Attract Investments
There has been a greater focus on development of novel therapeutics that contain high-potency active pharmaceutical ingredients (HPAPIs), which has resulted in a higher demand for these classes of small molecules. The manufacturing of high potency Ibuprofen API is an active area of investment from large scale Ibuprofen API manufacturers and contract manufacturers. The companies are actively investing into infrastructure development required to produce Ibuprofen HPAPIs.
Achieving Cost Efficiency with a Shift Towards CMOs
Outsourcing production of Ibuprofen formulation from Ibuprofen API to CMO saves on initial cost of formulation leading to significant cost benefits among key drug manufacturer. Additionally, CMO handles high volume of Ibuprofen API for production emerging as prominent end user.
Emerging Regional Markets Perform Amid High Costs Associated with Ibuprofen API
North America and Europe, being developed markets with higher adoption of NSAIDs and concentration of large manufacturers, are estimated to dominate the growth of the global Ibuprofen API market. Furthermore, South Asia and East Asia are expected to be highly profitable regions, as majority of Ibuprofen API nearly 80% is manufactured in these regions.
Intensified competition in low cost Ibuprofen API manufacturing countries such as China and India, and recent supply description in china and India have resulted in 25%-30% price hike in Ibuprofen API per kg. But amid this supply crunch Indian manufacturers are supplying the Ibuprofen API at previous rate have gained trust of industry participants and leading to growth of Ibuprofen API market.
Price Hike Certain Due to Coronavirus Outbreak
Prices of raw materials of ibuprofen API have experienced a significant hike due to the COVID-19 pandemic by about 20-50%. Wuhan, China, the origin of the pandemic, has been the production hub for a majority of raw materials required in manufacturing of active pharmaceutical ingredients (APIs). It is yet to witness production resume, and supplies from other Chinese sources also remain sluggish due to logistical alterations and challenges associated with government approvals.
Ibuprofen API Market Competition Analysis
Key manufacturers in the Ibuprofen API market such as SI Group, Inc., BASF SE, Hubei Biocause Phamaceutical Co., Ltd. (BIOCAUSE Inc.), IOL Chemicals, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., and Solara Active Pharma Sciences Limited are aiming at organic business expansions strategies by entering into sales agreement, mergers, joint ventures, and capacity expansion to gain share in developing economies.
Focusing on reduction in operating costs through outsourcing manufacturing and commercialization of API drugs to CMO could increase output. Outsourcing at earlier stages of in-house raw material development through strategic partner could improve efficiencies all along the value chain. Diverging to produce new formulation entirety such as granules and suspension is anticipated to benefit growth ibuprofen API market.
Base Year Considered
Actual Estimates/ Historical Data
2014 - 2018
2019 - 2029
Value (US$) Mn
End User and Region
North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA)
SI Group, Inc., BASF SE, Hubei Biocause Phamaceutical Co., Ltd. (BIOCAUSE Inc.), IOL Chemicals, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., Solara Active Pharma Sciences Limited
Revenue Forecasts, Company Share, Competitive Landscape, Growth Factors, and Trends
Contract Manufacturing Organization Remain Primary End User
Contract manufacturing organizations (CMO) are reinventing their strategies to align with the changing dynamics of pharmaceutical industry - cost reduction, and enhanced differentiation from peers. Prominent pharmaceutical companies highly rely on CMOs for manufacturing APIs as well as final formulations. Integration of CMOs into supply chain of pharmaceutical companies is becoming commonplace. CMOs are also pairing with other CMOs in a bid to offer combined services. This study further underlines that CMOs would generate 50% total return to shareholders through 2029.
Asia to Offer Second Wave of Growth
Driven by strong foothold of leading manufacturers and high adoption of non-steroidal anti-inflammatory drugs (NSAID), North America would remain the hub of investment opportunities in ibuprofen API market. However, Asia is expected to offer further opportunities of growth and profitability in the years ahead. Availability of cheap labor, and abundant raw materials needed to develop ibuprofen API are primarily responsible for market growth in the region. Conducive regulatory environment to set up manufacturing facilities, and reduced taxation policies are also significantly attracting stakeholders. Furthermore, majority of the antibiotic drugs and anti-inflammatory drugs are manufactured in Asia, of which, about 80% are developed in China, and India.
* This data is only a representation. Actual data may vary and will be available in report.
Mergers & Acquisitions - Critical to Market Progress
Various pharmaceutical companies in the ibuprofen API market are focusing on mergers & acquisitions with CMOs to establish their proprietary pharmaceutical intermediate and small molecule API units to enhance the supply of raw materials and keep up with the pace of the manufacturing of the final formulation. Over the recent past, the number of deals in pharma API industry has surged with the aim to address therapeutic, pipeline, and geographic expansion needs. Mergers & acquisitions thus play a big part in the growth tactics for majority of pharmaceutical companies in ibuprofen API market by saving time and costs.
Contract manufacturing organizations remain key end user
Application in pharmaceutical companies to rise
How Growth will Unfold
Several pharmaceutical and biopharmaceutical companies are aggressively moving toward enhanced production capacity to boost their global presence. For instance, BASF SE is looking forth to increase its production capabilities in Germany and the US. By 2023, the company expects to witness an upsurge in its capacity by over 30%. Moving on, the World Health Organization (WHO) states that incidents of chronic diseases will surge by around 60% in 2020, accenting the need for ibuprofen API. However, factors such as unstable supply of required components, and rise in raw material prices - Isobutyl Benzene - are likely to hamper the growth of ibuprofen API market. Manufacturers are confronting downward pricing pressure that leaves limited scope for innovation in manufacturing techniques. As such, the market is yet fully embrace tech-enabled transformations.
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
A recent market study published by Future Market Insights (FMI) offers ibuprofen API market global industry analysis for 2014-2018 and forecast for 2019-2029. The study also offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the ibuprofen API market, the growth prospects of the market are obtained with maximum precision.
Ibuprofen API Market Taxonomy
The global ibuprofen API market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
- Contract Manufacturing Organizations
- Pharmaceutical Companies
- North America
- Latin America
- South Asia
- East Asia
- Middle East and Africa
The report commences with the executive summary of the market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ Million) estimates of the leading segments of the market.
Readers can find the detailed segmentation and the definition of the market in this chapter, which will help them understand the basic information about the market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the market report.
The ibuprofen API market report provides the key market trends that are expected to significantly impact the market growth during the forecast period. Detailed industry trends are provided in this section.
This section includes the factors that have emerged as key successful factors and the strategies adopted by key market participants. Additional viewpoint on global average pricing analysis benchmark, consumer sentiment analysis, and value chain analysis, which are likely to contribute to market growth.
This section explains the global market volume analysis and forecast for the market between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical market volume, along with an opportunity analysis of the future. This section also explains the global market volume analysis and forecast for the market during the forecast period.
This chapter explains the key macroeconomic factors that are expected to influence the growth of the market during the forecast period. Along with the macroeconomic factors, this section also highlights the impact factors, supply chain, forecast factors, Porter’s five forces analysis, and value chain analysis for the market. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section. Moreover, readers will understand the key trends followed by the leading manufacturers in the market.
This section explains the global market value analysis and forecast for the market between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019-2029). Along with this, pricing analysis of the market at the regional level has been provided in this section.
This chapter provides details about the market on the basis of end user, and has been classified into contract manufacturing organizations and pharmaceutical companies. In this chapter, readers can understand the market attractiveness analysis based on end user.
This chapter explains how the market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
This chapter includes a detailed analysis of the growth of the North America, along with a country-wise assessment that includes the U.S. and Canada.
Readers can find detailed information about several factors such as the pricing analysis, which are impacting growth of the Latin America market. This chapter also includes the growth prospects of the ibuprofen API market in the leading Latin America countries such as Brazil, Mexico, and the Rest of Latin America.
Important growth prospects of the market based on its end users in several countries such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter.
India, Indonesia, Thailand, and Malaysia are among the leading countries in the South Asia region, which are the prime subjects of assessment to obtain the growth prospects of the South Asia market in this chapter. Readers can find detailed information about the growth parameters of the South Asia market during the period 2019-2029.
This chapter highlights the growth of the market in East Asia by focusing on China, Japan, and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the market in East Asia.
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania market.
This chapter provides information about how the market will grow in the major countries in the MEA region such as GCC Countries, South Africa, , and the rest of MEA, during the forecast period.
This chapter provides information about how the Ibuprofen API market in emerging countries will grow during the forecast period.
In this chapter, readers can find detailed information about the tier analysis and market concentration of the key players in the market, along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are SI Group, Inc., BASF SE, Hubei Biocause Phamaceutical Co., Ltd. (BIOCAUSE Inc.), IOL Chemicals, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., and Solara Active Pharma Sciences Limited.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the ibuprofen API market report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Device Development Heads
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Component Suppliers / OEMs
- Purchasing Departments
- Physicians / Nursing Managers
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Product Adoption, utilization rate, substitutes
- Regulatory Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Magazines
- Organisation for Economic Co-operation and Development
- Emergency Care Research Institute
- Global Clinical research Organizations
- Research organisations
- Company Press Releases
- Annual Reports and Investor Presentations
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Regulatory Authorities
- World Bank, WHO
Primary Interview Splits